Want to see MLSS full AI Analyst Report?
Milestone Scientific (MLSS) Ratios
Milestone Scientific Ratios
MLSS's free cash flow for Q2 2026 was $-589.27K. For the 2026 fiscal year, MLSS's free cash flow was decreased by $-4.14K and operating cash flow was $-585.13K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.81 | 2.48 | 3.51 | 3.93 | 6.11 |
| Quick Ratio | 0.89 | 1.49 | 2.65 | 3.39 | 5.62 |
| Cash Ratio | 0.27 | 0.87 | 0.97 | 2.64 | 4.77 |
| Solvency Ratio | -1.11 | -1.18 | -2.04 | -2.34 | -1.88 |
| Operating Cash Flow Ratio | -0.71 | -0.78 | -1.73 | -1.83 | -1.30 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.48M | $ 5.32M | $ 7.44M | $ 9.27M | $ 15.34M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.04 | 0.03 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.36 | 0.06 | 0.05 | 0.05 | 0.04 |
| Debt-to-Capital Ratio | 0.27 | 0.06 | 0.05 | 0.05 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.78 | 1.68 | 1.42 | 1.34 | 1.21 |
| Debt Service Coverage Ratio | -215.28 | 0.00 | 0.00 | 0.00 | -446.52 |
| Interest Coverage Ratio | -222.53 | 0.00 | 0.00 | 0.00 | -451.01 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | 0.02 | 0.62 | 0.37 | 0.94 | 1.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 70.53% | 74.56% | 69.12% | 55.65% | 61.25% |
| EBIT Margin | -63.48% | -54.62% | -72.31% | -100.24% | -71.60% |
| EBITDA Margin | -61.41% | -54.19% | -71.68% | -99.52% | -70.89% |
| Operating Profit Margin | -63.48% | -78.30% | -72.31% | -100.24% | -71.60% |
| Pretax Profit Margin | -63.76% | -54.62% | -71.04% | -99.62% | -66.73% |
| Net Profit Margin | -63.76% | -54.62% | -70.51% | -98.87% | -66.17% |
| Continuous Operations Profit Margin | -63.76% | -54.62% | -71.04% | -99.62% | -66.73% |
| Net Income Per EBT | 100.00% | 100.00% | 99.26% | 99.24% | 99.16% |
| EBT Per EBIT | 100.45% | 69.76% | 98.23% | 99.38% | 93.19% |
| Return on Assets (ROA) | -73.30% | -48.11% | -60.93% | -63.54% | -34.42% |
| Return on Equity (ROE) | -203.45% | -80.81% | -86.48% | -85.14% | -41.66% |
| Return on Capital Employed (ROCE) | -155.00% | -111.63% | -85.67% | -84.86% | -44.15% |
| Return on Invested Capital (ROIC) | -148.63% | -109.30% | -84.52% | -84.04% | -43.91% |
| Return on Tangible Assets | -74.05% | -48.85% | -61.91% | -64.61% | -34.91% |
| Earnings Yield | -25.54% | -6.15% | -13.80% | -25.69% | -4.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 12.71 | 18.15 | 31.43 | 12.69 | 10.92 |
| Payables Turnover | 1.85 | 2.15 | 2.76 | 2.05 | 3.39 |
| Inventory Turnover | 0.70 | 0.59 | 1.15 | 2.18 | 2.59 |
| Fixed Asset Turnover | 43.52 | 25.54 | 26.26 | 18.37 | 17.95 |
| Asset Turnover | 1.15 | 0.88 | 0.86 | 0.64 | 0.52 |
| Working Capital Turnover Ratio | 2.02 | 1.30 | 1.13 | 0.69 | 0.65 |
| Cash Conversion Cycle | 353.28 | 467.65 | 196.60 | 18.11 | 66.80 |
| Days of Sales Outstanding | 28.72 | 20.11 | 11.61 | 28.75 | 33.41 |
| Days of Inventory Outstanding | 521.96 | 617.36 | 317.30 | 167.53 | 140.92 |
| Days of Payables Outstanding | 197.40 | 169.82 | 132.31 | 178.17 | 107.53 |
| Operating Cycle | 550.68 | 637.47 | 328.91 | 196.28 | 174.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.04 | -0.04 | -0.07 | -0.09 | -0.06 |
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.07 | -0.09 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | -192.85 | -288.38 | -1091.20 | -707.40 | -264.51 |
| Capital Expenditure Coverage Ratio | -192.85 | -288.38 | -1091.20 | -707.40 | -264.51 |
| Operating Cash Flow Coverage Ratio | -2.86 | -8.37 | -13.45 | -12.14 | -6.85 |
| Operating Cash Flow to Sales Ratio | -0.33 | -0.34 | -0.54 | -0.68 | -0.39 |
| Free Cash Flow Yield | -13.09% | -3.83% | -10.62% | -17.82% | -2.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.90 | -16.24 | -7.25 | -3.89 | -20.80 |
| Price-to-Sales (P/S) Ratio | 2.50 | 8.88 | 5.11 | 3.85 | 13.76 |
| Price-to-Book (P/B) Ratio | 7.97 | 13.13 | 6.27 | 3.31 | 8.66 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.64 | -26.14 | -9.42 | -5.61 | -35.16 |
| Price-to-Operating Cash Flow Ratio | -7.68 | -26.23 | -9.43 | -5.62 | -35.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.21 | 0.43 | 0.35 | -0.19 | 1.25 |
| Enterprise Value Multiple | -4.05 | -15.76 | -6.76 | -2.93 | -17.47 |
| Enterprise Value | 22.31M | 73.69M | 47.63M | 25.67M | 127.61M |
| EV to EBITDA | -4.05 | -15.76 | -6.76 | -2.93 | -17.47 |
| EV to Sales | 2.49 | 8.54 | 4.85 | 2.92 | 12.38 |
| EV to Free Cash Flow | -7.61 | -25.15 | -8.93 | -4.25 | -31.64 |
| EV to Operating Cash Flow | -7.65 | -25.24 | -8.94 | -4.26 | -31.76 |
| Tangible Book Value Per Share | 0.03 | 0.07 | 0.11 | 0.14 | 0.23 |
| Shareholders’ Equity Per Share | 0.03 | 0.07 | 0.11 | 0.14 | 0.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.11 | 0.11 | 0.14 | 0.12 | 0.15 |
| Net Income Per Share | -0.07 | -0.06 | -0.10 | -0.12 | -0.10 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 0.99 | 0.99 |
| Interest Burden | 1.00 | 1.00 | 0.98 | 0.99 | 0.93 |
| Research & Development to Revenue | 0.05 | 0.10 | 0.07 | 0.13 | 0.09 |
| SG&A to Revenue | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.11 | 0.20 | 0.19 | 0.21 | 0.15 |
| Income Quality | 0.51 | 0.62 | 0.77 | 0.69 | 0.58 |
Currency in USD